Cargando…
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801863/ https://www.ncbi.nlm.nih.gov/pubmed/33433843 http://dx.doi.org/10.1007/s11845-020-02482-2 |
| _version_ | 1783635661260062720 |
|---|---|
| author | Vitiello, Antonio Ferrara, Francesco Porta, Raffaele La |
| author_facet | Vitiello, Antonio Ferrara, Francesco Porta, Raffaele La |
| author_sort | Vitiello, Antonio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7801863 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78018632021-01-12 Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Vitiello, Antonio Ferrara, Francesco Porta, Raffaele La Ir J Med Sci Letter to the Editor Springer International Publishing 2021-01-12 2021 /pmc/articles/PMC7801863/ /pubmed/33433843 http://dx.doi.org/10.1007/s11845-020-02482-2 Text en © Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Vitiello, Antonio Ferrara, Francesco Porta, Raffaele La Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title | Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title_full | Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title_fullStr | Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title_full_unstemmed | Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title_short | Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? |
| title_sort | remdesivir and covid-19 infection, therapeutic benefits or unnecessary risks? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801863/ https://www.ncbi.nlm.nih.gov/pubmed/33433843 http://dx.doi.org/10.1007/s11845-020-02482-2 |
| work_keys_str_mv | AT vitielloantonio remdesivirandcovid19infectiontherapeuticbenefitsorunnecessaryrisks AT ferrarafrancesco remdesivirandcovid19infectiontherapeuticbenefitsorunnecessaryrisks AT portaraffaelela remdesivirandcovid19infectiontherapeuticbenefitsorunnecessaryrisks |